Anti-Vaping Messages for Reducing Nicotine Use in Young Adults
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to examine how different anti-vaping messages affect young adult vapers who do not currently smoke cigarettes. Researchers seek to understand how these messages influence brain activity, using brain scans, and whether this alters vaping habits over a year. Participants will be divided into groups to receive either general anti-vaping messages, messages focusing on the harms of flavored vapes, or no messages, with some switching message types halfway through. The trial is ideal for young adults who have vaped at least three times in the last month but have not smoked cigarettes during that time. As an unphased trial, it offers a unique opportunity to contribute to important research on vaping behaviors and brain responses.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these anti-vaping messages are safe for young adults?
Research shows that anti-vaping public service announcements (PSAs) are generally well-received by young adults. These announcements aim to discourage vaping and inform young people about the risks of using e-cigarettes. Studies have found that these messages can effectively increase awareness about the health risks of vaping without causing major negative reactions.
For example, the campaign "The Real Cost" targets youth and highlights the potential harms of e-cigarettes. It successfully educated middle and high school students about the dangers, without any reported negative effects. Additionally, research has found that young adults often share social media messages about the harms of vaping, indicating that the content is engaging and not upsetting to the audience.
Overall, exposure to anti-vaping messages appears safe, with no significant safety concerns reported in the available studies.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to curb nicotine use among young adults through targeted messaging. Traditional approaches to reducing vaping often involve counseling, nicotine replacement therapies, or medications. However, this study tests the impact of exposure to anti-vaping messages delivered via emails and texts, focusing first on either general negative consequences or specific harms of flavored e-cigarettes. By comparing the effectiveness of different messaging sequences, researchers hope to discover a more effective strategy for reducing vaping rates. This approach is particularly innovative because it leverages digital communication to directly influence behavior, potentially offering a scalable and personalized intervention.
What evidence suggests that this trial's anti-vaping messages could be effective for reducing nicotine use in young adults?
Studies have shown that anti-vaping public service announcements (PSAs) can lead people to view e-cigarettes more negatively and perceive them as more harmful. Research indicates that these messages can reduce vaping and smoking among young people. In this trial, participants will encounter different sequences of anti-vaping messages. One group will receive regular PSAs followed by flavor-specific PSAs, while another group will receive flavor-specific PSAs followed by regular PSAs. A previous study found that a text message program helped teenagers quit vaping, suggesting that targeted messages can be effective. A review of several studies also supports the idea that health messages can help prevent and stop e-cigarette use in both young people and young adults. Overall, the evidence suggests that exposure to anti-vaping messages can be a useful tool in reducing nicotine use.12367
Are You a Good Fit for This Trial?
This trial is for young adult vapers who haven't smoked cigarettes in the past month, have used e-cigarettes on at least 3 days in that time, and can safely undergo MRI scans. It's not for those with recent cigarette use, major health disorders, or MRI contraindications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline fMRI
Participants undergo a baseline fMRI scan to assess neurocognitive markers
Intervention
Participants receive weekly anti-vaping PSAs and complete online surveys
In-person Assessments
Participants complete in-person assessments to biochemically confirm nicotine exposure
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Exposure to Anti-Vaping Messages (flavor-specific themes then generic themes)
- Exposure to Anti-Vaping Messages (generic themes then flavor-specific themes)
- Exposure to Anti-Vaping Messages (no message exposure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Georgia
Lead Sponsor